Fig. 1From: Chemotherapy receipt in affected BRCA1/2 and PALB2 carriers with operable breast cancer: the impact of early detection and pre-diagnostic awareness on clinical outcomes and treatmentCohort selectionBack to article page
Hereditary Cancer in Clinical Practice